Addus HomeCare (ADUS) CEO stock grant and tax-driven share sale

Rhea-AI Filing Summary

Addus HomeCare Corp Chairman and CEO Allison R. Dirk reported both a stock grant and a tax-related share sale. He received a grant of 28,576 shares of common stock that vest in equal parts on February 20 of 2027, 2028, and 2029. He also sold 4,535 shares at $114.91 per share under a previously established Rule 10b5-1 plan to cover tax obligations from restricted stock vesting, and held 190,502 shares afterward.

Insider Trade Summary

Net Seller: 4,535 shares ($521,117)

Net Sell 2 txns

Insider ALLISON R DIRK

Role Chairman and CEO

Sold 4,535 shs ($521K)

Type	Security	Shares	Price	Value
Sale	Common Stock	4,535	$114.91	$521K
Grant/Award	Common Stock	28,576	$0.00	--

Holdings After Transaction: Common Stock — 190,502 shares (Direct)

Footnotes (1)

1. The shares vest in equal installments on each of February 20, 2027, February 20, 2028, and February 20, 2029, subject to customary provisions for continued service and acceleration on a change in control. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer. Adoption date of referenced 10b5-1(c) plan is: 03-04-2025

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ALLISON R DIRK

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TX 75034

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		A		28,576(1)	A	$0	195,037	D
Common Stock	02/23/2026		S(2)(3)		4,535	D	$114.91	190,502	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares vest in equal installments on each of February 20, 2027, February 20, 2028, and February 20, 2029, subject to customary provisions for continued service and acceleration on a change in control.

2. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.

3. Adoption date of referenced 10b5-1(c) plan is: 03-04-2025

	/s/ Brian Poff, Attorney-in-Fact for R. Dirk Allison	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Addus HomeCare (ADUS) CEO Allison R. Dirk report?

Allison R. Dirk reported a stock grant and a share sale. He received 28,576 shares of Addus HomeCare common stock and sold 4,535 shares at $114.91 each under a pre-established Rule 10b5-1 trading plan to satisfy tax obligations on vested restricted stock awards.

How many Addus HomeCare (ADUS) shares were granted to the CEO and how do they vest?

The CEO was granted 28,576 shares of Addus HomeCare common stock. These shares vest in three equal installments on February 20, 2027, February 20, 2028, and February 20, 2029, subject to continued service and standard provisions, including potential acceleration upon a change in control.

How many Addus HomeCare (ADUS) shares did the CEO sell and at what price?

The CEO sold 4,535 shares of Addus HomeCare common stock. The reported sale price was $114.91 per share. The filing describes this as an open-market sale executed under a previously established Rule 10b5-1 trading plan linked to tax obligations from restricted stock vesting.

Why did the Addus HomeCare (ADUS) CEO sell shares according to the Form 4?

The share sale was made to satisfy tax obligations. The filing states the 4,535 shares were sold under a previously established Rule 10b5-1 plan specifically to cover taxes due upon the vesting of restricted stock awards granted by Addus HomeCare to the CEO.

How many Addus HomeCare (ADUS) shares does the CEO hold after these transactions?

After the reported transactions, the CEO directly held 190,502 shares of Addus HomeCare common stock. This figure comes from the Form 4 line associated with the 4,535-share sale and reflects his direct ownership position following completion of that tax-related transaction.

What is the Rule 10b5-1 trading plan mentioned in the Addus HomeCare (ADUS) Form 4?

The Rule 10b5-1 plan is a pre-arranged trading program. The filing notes the sale was made under a previously established 10b5-1(c) plan, adopted on 03-04-2025, which allowed scheduled sales to satisfy tax obligations from restricted stock vesting without ad hoc trading decisions.